| 000 | 01781 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250515003645.0 | ||
| 264 | 0 | _c20060112 | |
| 008 | 200601s 0 0 eng d | ||
| 022 | _a1042-8194 | ||
| 024 | 7 |
_a10.1080/10428190500217312 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aVose, J M | |
| 245 | 0 | 0 |
_aLong-term update of a phase II study of rituximab in combination with CHOP chemotherapy in patients with previously untreated, aggressive non-Hodgkin's lymphoma. _h[electronic resource] |
| 260 |
_bLeukemia & lymphoma _cNov 2005 |
||
| 300 |
_a1569-73 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial, Phase II; Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xadministration & dosage |
| 650 | 0 | 4 | _aAntibodies, Monoclonal, Murine-Derived |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadministration & dosage |
| 650 | 0 | 4 | _aCause of Death |
| 650 | 0 | 4 |
_aCyclophosphamide _xadministration & dosage |
| 650 | 0 | 4 |
_aDoxorubicin _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLymphoma, B-Cell _xdrug therapy |
| 650 | 0 | 4 |
_aLymphoma, Non-Hodgkin _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPrednisone _xadministration & dosage |
| 650 | 0 | 4 | _aRemission Induction |
| 650 | 0 | 4 | _aRituximab |
| 650 | 0 | 4 | _aSurvival Analysis |
| 650 | 0 | 4 |
_aVincristine _xadministration & dosage |
| 700 | 1 | _aLink, B K | |
| 700 | 1 | _aGrossbard, M L | |
| 700 | 1 | _aCzuczman, M | |
| 700 | 1 | _aGrillo-Lopez, A | |
| 700 | 1 | _aFisher, R I | |
| 773 | 0 |
_tLeukemia & lymphoma _gvol. 46 _gno. 11 _gp. 1569-73 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1080/10428190500217312 _zAvailable from publisher's website |
| 999 |
_c15864626 _d15864626 |
||